Microbiology, Virology, Immunology, Cancer, Epidemiology, Vaccinology, Immunotherapy
The Institut Pasteur Shanghai (IPS) is the first international institute under the Chinese Academy of Sciences (CAS). Founded in 2004 by CAS, the Institut Pasteur and the Shanghai Municipal Government, IPS is an independent, nonprofit life sciences institute that works closely with Chinese authorities to address public health problems. IPS creates synergies between the Institut Pasteur and CAS networks, leveraging all the assets of Shanghai, one of Asia’s leading business and technology hubs. IPS is engaged in broad research related to infectious diseases, including research on HIV, viral hepatitis B and C, respiratory viruses and virus-induced cancers, etc. Together with its academic and industry partners, IPS’s goal is to develop diagnostic, vaccine and therapeutic products to meet the healthcare challenges.
Institut Pasteur of Shanghai, Chinese Academy of Sciences (IPS-CAS) aims to translate excellence in science for the benefit of public health, to contribute to disease prevention and control through innovative basic and applied research. By the end of 2016, IPS-CAS was strong of over 250 scientists with 27 teams and it will grow further after relocating to its new building.
Infectious Diseases know no borders and are common concern to all countries in the region and the world, which requests joint efforts from every institution. The institute looks forward to cooperation with national and international colleagues to meet new challenges and contribute to improvement of public health.